Global Scientific Director, Rare Bleeding DisordersNovo Nordisk Health Care AG, Zurich, SwitzerlandZurich, Zurich, Switzerland
OC 51.1 - Incidence of thromboembolic events among women with severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis
Tuesday, June 25, 202409:30 – 09:45 ICT
